H
HCLC
vs
S&P 500
S&P 500
Over the past 12 months, HCLC has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +14% growth.
Stocks Performance
HCLC vs S&P 500
Performance Gap
HCLC vs S&P 500
Performance By Year
HCLC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Health-Chem Corp
Glance View
Health-Chem Corp. develops, manufactures and markets transdermal drug delivery systems. The company is headquartered in New York City, New York and currently employs 206 full-time employees. Transderm owns 98.5% of Hercon Laboratories Corporation, which develops and manufactures controlled release products for the pharmaceutical industry, at Transderm's Pennsylvania facility, to deliver a variety of drugs topically or transdermally. The firm has manufactured over-the-counter pharmaceutical and cosmetic products that are used to clean facial pores. These deep cleansing facial pore strips are designed to remove clogged dirt, oil and blackheads from the nose, chin, forehead and anywhere else on the face that needs deep cleaning. In addition to its nitroglycerin transdermal products, the Company is also developing transdermal products for hormone replacement therapies.
